163 related articles for article (PubMed ID: 33565603)
1. Development of cell-based high throughput luminescence assay for drug discovery in inhibiting OCT4/DNA-PKcs and OCT4-MK2 interactions.
Mohiuddin IS; Wei SJ; Yang IH; Martinez GM; Yang S; Cho EJ; Dalby KN; Kang MH
Biotechnol Bioeng; 2021 May; 118(5):1987-2000. PubMed ID: 33565603
[TBL] [Abstract][Full Text] [Related]
2. DNA-PKcs as an upstream mediator of OCT4-induced MYC activation in small cell lung cancer.
Wei SJ; Yang IH; Mohiuddin IS; Kshirsagar GJ; Nguyen TH; Trasti S; Maurer BJ; Kang MH
Biochim Biophys Acta Gene Regul Mech; 2023 Jun; 1866(2):194939. PubMed ID: 37116859
[TBL] [Abstract][Full Text] [Related]
3. MYC transcription activation mediated by OCT4 as a mechanism of resistance to 13-cisRA-mediated differentiation in neuroblastoma.
Wei SJ; Nguyen TH; Yang IH; Mook DG; Makena MR; Verlekar D; Hindle A; Martinez GM; Yang S; Shimada H; Reynolds CP; Kang MH
Cell Death Dis; 2020 May; 11(5):368. PubMed ID: 32409685
[TBL] [Abstract][Full Text] [Related]
4. From Enzyme to Whole Blood: Sequential Screening Procedure for Identification and Evaluation of p38 MAPK Inhibitors.
Bauer SM; Kubiak JM; Rothbauer U; Laufer S
Methods Mol Biol; 2016; 1360():123-48. PubMed ID: 26501907
[TBL] [Abstract][Full Text] [Related]
5. miR-296-3p Negatively Regulated by Nicotine Stimulates Cytoplasmic Translocation of c-Myc via MK2 to Suppress Chemotherapy Resistance.
Deng X; Liu Z; Liu X; Fu Q; Deng T; Lu J; Liu Y; Liang Z; Jiang Q; Cheng C; Fang W
Mol Ther; 2018 Apr; 26(4):1066-1081. PubMed ID: 29525743
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of c-myc protein by siRNA-mediated silencing of DNA-PKcs in HeLa cells.
An J; Xu QZ; Sui JL; Bai B; Zhou PK
Int J Cancer; 2005 Nov; 117(4):531-7. PubMed ID: 15929110
[TBL] [Abstract][Full Text] [Related]
7. DNA-dependent protein kinase catalytic subunit modulates the stability of c-Myc oncoprotein.
An J; Yang DY; Xu QZ; Zhang SM; Huo YY; Shang ZF; Wang Y; Wu DC; Zhou PK
Mol Cancer; 2008 Apr; 7():32. PubMed ID: 18426604
[TBL] [Abstract][Full Text] [Related]
8. High-Throughput Screening and Triage Assays Identify Small Molecules Targeting c-MYC in Cancer Cells.
Kallal LA; Waszkiewicz A; Jaworski JP; Della Pietra A; Berrodin T; Brady P; Jurewicz AJ; Zeng X; Payne L; Medina JR; Doepner-Buser C; Mangatt B
SLAS Discov; 2021 Feb; 26(2):216-229. PubMed ID: 33482073
[TBL] [Abstract][Full Text] [Related]
9. Strand-specific PCR of UV radiation-damaged genomic DNA revealed an essential role of DNA-PKcs in the transcription-coupled repair.
An J; Yang T; Huang Y; Liu F; Sun J; Wang Y; Xu Q; Wu D; Zhou P
BMC Biochem; 2011 Jan; 12():2. PubMed ID: 21214942
[TBL] [Abstract][Full Text] [Related]
10. Endoplasmic reticulum-associated ubiquitin-conjugating enzyme Ube2j1 is a novel substrate of MK2 (MAPKAP kinase-2) involved in MK2-mediated TNFα production.
Menon MB; Tiedje C; Lafera J; Ronkina N; Konen T; Kotlyarov A; Gaestel M
Biochem J; 2013 Dec; 456(2):163-72. PubMed ID: 24020373
[TBL] [Abstract][Full Text] [Related]
11. DNA-PKcs plays a dominant role in the regulation of H2AX phosphorylation in response to DNA damage and cell cycle progression.
An J; Huang YC; Xu QZ; Zhou LJ; Shang ZF; Huang B; Wang Y; Liu XD; Wu DC; Zhou PK
BMC Mol Biol; 2010 Mar; 11():18. PubMed ID: 20205745
[TBL] [Abstract][Full Text] [Related]
12. Threonine 2609 phosphorylation of the DNA-dependent protein kinase is a critical prerequisite for epidermal growth factor receptor-mediated radiation resistance.
Javvadi P; Makino H; Das AK; Lin YF; Chen DJ; Chen BP; Nirodi CS
Mol Cancer Res; 2012 Oct; 10(10):1359-68. PubMed ID: 22923485
[TBL] [Abstract][Full Text] [Related]
13. p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication.
Cannell IG; Kong YW; Johnston SJ; Chen ML; Collins HM; Dobbyn HC; Elia A; Kress TR; Dickens M; Clemens MJ; Heery DM; Gaestel M; Eilers M; Willis AE; Bushell M
Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5375-80. PubMed ID: 20212154
[TBL] [Abstract][Full Text] [Related]
14. AKT1, LKB1, and YAP1 Revealed as MYC Interactors with NanoLuc-Based Protein-Fragment Complementation Assay.
Mo X; Qi Q; Ivanov AA; Niu Q; Luo Y; Havel J; Goetze R; Bell S; Moreno CS; Cooper LA; Johns MA; Khuri FR; Du Y; Fu H
Mol Pharmacol; 2017 Apr; 91(4):339-347. PubMed ID: 28087810
[TBL] [Abstract][Full Text] [Related]
15. A p38 substrate-specific MK2-EGFP translocation assay for identification and validation of new p38 inhibitors in living cells: a comprising alternative for acquisition of cellular p38 inhibition data.
Anton R; Bauer SM; Keck PR; Laufer S; Rothbauer U
PLoS One; 2014; 9(4):e95641. PubMed ID: 24743242
[TBL] [Abstract][Full Text] [Related]
16. Theoretical analysis of the binding of potential inhibitors to protein kinases MK2 and MK3.
Araújo PM; da Silva LP; Esteves da Silva JC
Med Chem; 2015; 11(6):573-9. PubMed ID: 25665652
[TBL] [Abstract][Full Text] [Related]
17. Mitogen-activated protein kinase-activated protein kinase 2 mediates resistance to hydrogen peroxide-induced oxidative stress in human hepatobiliary cancer cells.
Nguyen Ho-Bouldoires TH; Clapéron A; Mergey M; Wendum D; Desbois-Mouthon C; Tahraoui S; Fartoux L; Chettouh H; Merabtene F; Scatton O; Gaestel M; Praz F; Housset C; Fouassier L
Free Radic Biol Med; 2015 Dec; 89():34-46. PubMed ID: 26169728
[TBL] [Abstract][Full Text] [Related]
18. Treatment with MAPKAP2 (MK2) inhibitor and DNA methylation inhibitor, 5-aza dC, synergistically triggers apoptosis in hepatocellular carcinoma (HCC) via tristetraprolin (TTP).
Tran DDH; Koch A; Allister A; Saran S; Ewald F; Koch M; Nashan B; Tamura T
Cell Signal; 2016 Dec; 28(12):1872-1880. PubMed ID: 27619201
[TBL] [Abstract][Full Text] [Related]
19. 4-Anilino-6-phenyl-quinoline inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK2).
Olsson H; Sjö P; Ersoy O; Kristoffersson A; Larsson J; Nordén B
Bioorg Med Chem Lett; 2010 Aug; 20(16):4738-40. PubMed ID: 20643547
[TBL] [Abstract][Full Text] [Related]
20. Assay development and case history of a 32K-biased library high-content MK2-EGFP translocation screen to identify p38 mitogen-activated protein kinase inhibitors on the ArrayScan 3.1 imaging platform.
Trask OJ; Baker A; Williams RG; Nickischer D; Kandasamy R; Laethem C; Johnston PA; Johnston PA
Methods Enzymol; 2006; 414():419-39. PubMed ID: 17110205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
